BMO Capital Reaffirms Outperform Rating on Vertex Pharmaceuticals (NASDAQ: VRTX) Amid Strategic Acquisitions and FDA Approval
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameBank of Montreal
-
Registration countryCanada
-
IndustryBanks
-
М/S&P/F
*** /*** /***









